Published in Eur J Surg Oncol on December 01, 2001
A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol (2009) 2.00
Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol (2006) 1.33
Phyllodes tumours of the breast: a consensus review. Histopathology (2016) 1.02
Malignant phyllode tumor metastatic to the duodenum. World J Gastroenterol (2006) 0.99
Phyllodes tumor of breast: a review article. ISRN Surg (2013) 0.98
The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan. Int J Clin Oncol (2012) 0.83
Huge malignant phyllodes breast tumor: a real entity in a new era of early breast cancer. World J Surg Oncol (2015) 0.83
Aggressive malignant phyllodes tumor. Int J Surg Case Rep (2015) 0.82
Anemia and jejunal intussusception: An unusual presentation for a metastatic phyllodes breast tumor. Int J Surg Case Rep (2011) 0.78
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. World J Surg (2016) 0.77
Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysis. Mol Clin Oncol (2015) 0.77
Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases. Breast J (2016) 0.75
Bone metastasis from malignant phyllodes breast tumor: report of two cases. BMC Clin Pathol (2016) 0.75
Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins. Mod Pathol (2016) 0.75
Current Trends in the Management of Phyllodes Tumors of the Breast. Ann Surg Oncol (2016) 0.75
Malignant and borderline phyllodes tumor of breast treated with a multi-modality approach in a tertiary cancer care centre in North India. South Asian J Cancer (2016) 0.75
Giant malignant phyllodes tumor of the breast: A rare case report and literature review. Oncol Lett (2016) 0.75
Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival: A case report and literature review. Medicine (Baltimore) (2016) 0.75
An Ulcerated Giant Malignant Phyllodes Tumour Presenting in Septic Shock. J Clin Diagn Res (2016) 0.75
Malignant Phyllodes Tumor of the Breast Metastasizing to the Vulva: (18)F-FDG PET-CT Demonstrating Rare Metastasis from a Rare Tumor. Nucl Med Mol Imaging (2012) 0.75
Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. J Thorac Dis (2016) 0.75
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol (2008) 3.44
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2009) 2.73
Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol (2000) 2.67
Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ (1999) 2.21
Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol (1999) 2.16
Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med (1996) 1.99
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol (2006) 1.85
Human papillomavirus and mixed epithelial tumors of the endometrium. Hum Pathol (1998) 1.66
Squamous cell carcinoma of the breast: clinico-pathologic implications and outcome. Eur J Surg Oncol (2003) 1.60
Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol (2001) 1.52
Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer (1999) 1.52
A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manage (2001) 1.44
The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia (1988) 1.41
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol (2009) 1.40
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res Treat (1998) 1.39
Nipple excised and areola retained after total mastectomy (NEAT). J R Soc Med (2001) 1.39
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
A more rational basis for determining the activities used for radionuclide imaging? Eur J Nucl Med (1997) 1.37
Treatment and outcome of intracystic papillary carcinoma of the breast. Br J Surg (1999) 1.34
Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol (2006) 1.33
Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer (1999) 1.28
A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol (2000) 1.27
Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer (2000) 1.23
Early changes in apoptosis and proliferation following primary chemotherapy for breast cancer. Br J Cancer (2003) 1.18
Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg (2004) 1.12
Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible? Fertil Steril (2000) 1.12
The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ (2001) 1.11
Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. Clin Radiol (2010) 1.08
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer (1999) 1.08
Granulomatous appendicitis. Surgeon (2003) 1.08
The basic pathology of human breast cancer. J Mammary Gland Biol Neoplasia (2000) 1.07
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer (2000) 1.07
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin. Br J Cancer (2012) 1.06
Overview of devolution of health services in the Philippines. Rural Remote Health (2003) 1.05
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer. Br J Cancer (2012) 1.04
Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer (1992) 1.03
Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage (2001) 1.01
Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Eur J Surg Oncol (2004) 1.00
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer. Br J Cancer (2004) 0.99
The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med (1998) 0.99
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. Br J Cancer (2010) 0.99
Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources. J Soc Gynecol Investig (2000) 0.98
Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. Br J Surg (2004) 0.98
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer (1997) 0.97
Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol (2000) 0.96
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer. Ann Oncol (2014) 0.94
The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer (1992) 0.94
Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol (1998) 0.94
The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer. Thyroid (2001) 0.91
Clinical presentation and long-term outcome of pure myoepithelial carcinoma of the breast. Eur J Surg Oncol (2004) 0.91
Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century. Clin Oncol (R Coll Radiol) (2003) 0.90
Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol (1998) 0.89
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts. Int J Cancer (1999) 0.89
Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer (2000) 0.87
Outcome of malignant spinal cord compression at a cancer center: implications for palliative care services. J Pain Symptom Manage (2000) 0.87
Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer. Ann Oncol (2012) 0.87
Prediction of survival in a hospital-based continuing care unit. Eur J Cancer (1994) 0.86
MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival. Cell Death Differ (2000) 0.86
Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. Int J Gynecol Cancer (2004) 0.85
The role of genetic factors in predisposition to squamous cell cancer of the head and neck. Br J Cancer (1999) 0.85
Gestational trophoblastic disease with liver metastases: the Charing Cross experience. Br J Obstet Gynaecol (1997) 0.85
Good manners for the pharmaceutical industry. Lancet (1997) 0.85
Spontaneous regression of extramammary Paget's disease after excision of primary apocrine carcinoma, in an immunosuppressed patient. Br J Dermatol (2005) 0.85
The use of the Rotterdam Symptom Checklist in palliative care. J Pain Symptom Manage (1999) 0.85
Multimodality therapy in inflammatory breast cancer: is there a place for surgery? Ann Oncol (2000) 0.84
Unusual presentation of an appendiceal malignancy. Int Surg (2006) 0.84
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma. Ann Oncol (2009) 0.83
The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer. Br J Cancer (1999) 0.83
New insights into p53 protein stabilisation in oral squamous cell carcinoma. Oral Oncol (1999) 0.83
Using an interactive video disk in breast cancer patient support. Nurs Times (1999) 0.82
Calponin and h-caldesmon expression in synovial sarcoma; the use of calponin in diagnosis. Histopathology (2003) 0.81
Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck. Oral Oncol (2005) 0.81
A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma. Eur J Cancer (1994) 0.81
Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer (2006) 0.81
Buttock soft tissue sarcoma: clinical features, treatment, and prognosis. Ann Surg Oncol (2003) 0.80
Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma. Br J Dermatol (2007) 0.80
Intracellular Ca(2+) regulation and electrophysiolgical properties of bladder urothelium subjected to stretch and exogenous agonists. Cell Calcium (2011) 0.80
Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Eur J Surg Oncol (2005) 0.80
Tumour marker levels during marimastat therapy. Lancet (1996) 0.80
The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography? Eur J Cancer (2001) 0.80
Outcome of treatment for limb and limb girdle sarcomas at the Royal Marsden Hospital. Eur J Surg Oncol (2000) 0.79
Surgical technique: submuscular placement of breast implant ports with delayed expansion following ultrasound localization. Eur J Surg Oncol (2001) 0.79
Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast. Cancer Lett (2001) 0.79
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Ann Oncol (2015) 0.79
Identification of patients at low risk of dying after acute myocardial infarction, by simple clinical and submaximal exercise test criteria. Eur Heart J (1988) 0.79
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trial. Ann Oncol (2010) 0.79
Detection of loco-regional recurrence after breast-conserving surgery and radiotherapy. J R Coll Surg Edinb (1995) 0.79
Normal and SV40 transfected human peritoneal mesothelial cells produce IL-6 and IL-8: implication for gynaecological disease. Clin Exp Immunol (2002) 0.78
Comparative distribution and use of humour within nurse-patient communication. Int J Nurs Stud (1996) 0.78
Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med (1998) 0.78
No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours. Br J Cancer (2001) 0.77
Patient-specific mutation databases for oral cancer. Int J Cancer (1999) 0.76
An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer (2005) 0.76
The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin Radiol (2003) 0.76
Clinical outcome and service implications of screening women at increased breast cancer risk from a family history. Eur J Surg Oncol (2006) 0.76
The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance. Br J Cancer (1997) 0.76
Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. Br J Radiol (2006) 0.75